https://www.corerxpharma.com/wp-content/uploads/2021/12/CoreRx-Announces-addition-of-Ryan-McFarlane-as-Executive-Director-Operational-Excellence-1.jpg
687
1030
Mark DaFonseca
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Mark DaFonseca2021-12-15 13:58:522021-12-15 14:03:12CoreRx Announces addition of Ryan McFarlane as Executive Director, Operational Excellence
https://www.corerxpharma.com/wp-content/uploads/2021/12/An-Interview-with-Ajay-Damani-CEO-CoreRx.jpg
687
1030
Mark DaFonseca
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Mark DaFonseca2021-12-10 13:57:132021-12-10 13:57:13An Interview with... Ajay Damani - CEO, CoreRx
https://www.corerxpharma.com/wp-content/uploads/2021/11/CoreRx-Announces-Successful-US-FDA-Inspection-of-Clearwater-Facility.jpg
600
900
Mark DaFonseca
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Mark DaFonseca2021-11-22 13:47:262021-11-22 14:04:49CoreRx Announces Successful US FDA Inspection of Clearwater Facility
https://www.corerxpharma.com/wp-content/uploads/2021/08/Hank4.jpg
687
1030
Mark DaFonseca
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Mark DaFonseca2021-08-02 12:45:302021-08-02 13:24:52CoreRx Announces New Leadership of Commercial Team
https://www.corerxpharma.com/wp-content/uploads/2021/07/CoreRx-Investment.jpg
812
1030
Mark DaFonseca
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Mark DaFonseca2021-07-01 11:49:212021-07-01 13:31:29CoreRx Adds Investment to Expand Oral Dosage Form Capabilities
https://www.corerxpharma.com/wp-content/uploads/2021/05/Nucleo3.jpg
812
1030
Mark DaFonseca
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Mark DaFonseca2021-05-24 11:36:592021-05-24 12:00:58CoreRx Acquires Nucleo Life Sciences
https://www.corerxpharma.com/wp-content/uploads/2021/04/Schedule-I-controlled-substances.jpg
812
1030
Mark DaFonseca
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Mark DaFonseca2021-04-30 13:34:302021-04-30 13:34:30CoreRx Inc. receives approval for Schedule I controlled drug manufacture
https://www.corerxpharma.com/wp-content/uploads/2020/04/Screen-Shot-2020-04-20-at-8.50.11-AM-e1601485420884.png
251
300
Devin Daviau
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Devin Daviau2020-08-03 18:46:292020-08-03 18:50:04CORERX, INC. FULLY OPERATIONAL IN NEW PRODUCT DEVELOPMENT CENTER
https://www.corerxpharma.com/wp-content/uploads/2015/10/graph-lab.png
430
1500
Devin Daviau
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Devin Daviau2020-03-25 15:59:552020-03-25 16:41:26CoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with long-standing client Bionpharma Inc.
https://www.corerxpharma.com/wp-content/uploads/2018/07/iStock_85158239_XXLARGE.jpg
3744
4748
Devin Daviau
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Devin Daviau2020-02-04 09:00:212020-02-04 13:36:14JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer for Phase 2b clinical formulation and development